Search
IQVIA Holdings Inc
IQVAdd to Watchlist
242.515USD
+3.815+1.60%
Close 08-10 16:00（ET）Quotes delayed by 15 min
39.83BMarket Cap
29.86P/E TTM
Forecast
Currency: USD Updated: 2026-08-10The current earnings forecast score of IQVIA Holdings Inc is 8.33, ranking 140 out of 387 in the Biotechnology & Medical Research industry. The average price target is 254.00, with a high of 270.00 and a low of 200.00.
Analyst Rating
Based on
24
analysts
Buy
Current Rating
272.651
Target Price
+14.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
IQVIA Holdings Inc
IQV
24
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is IQVIA Holdings Inc's expected revenue for the next quarter?
IQVIA Holdings Inc's expected revenue is 4.36B.
What is IQVIA Holdings Inc's price target?
Analysts forecast that IQVIA Holdings Inc's price target is USD 254.00, with the highest forecast at USD 270.00 and the lowest forecast at USD 200.00.
How have IQVIA Holdings IncIQV's recent earnings per share performed?
The market expectation was USD 1.54, while IQVIA Holdings IncIQV's earnings per share (EPS) for the previous quarter was USD 1.63. EPS for the next quarter is expected at USD 3.26.
What is the analyst rating for IQVIA Holdings Inc?
Based on the ratings of IQVIA Holdings Inc's stock from 24 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.